If US companies implement mandates, it will drive employed workforce away from the US business workforce to companies outside the US. The flexibility to work from your home allows for the shift.
It is a voluntary reporting system that has been estimated to account for only 1% (see the Lazarus Report) of vaccine injuries. OpenVAERS is built from the HHS data-available for download at https://t.co/rmUmA5KH6Q. https://t.co/qgIUWo3hpW.
Open VAERS - data from the Vaccine Adverse Event Reporting System. Sharing for those to have an opportunity to make an informed decision https://t.co/JCX2kBx37Q
Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US | SpringerLink https://t.co/nBkvXE3GhW
At Taysha, patients impacted by #rarediseases are at the center of everything we do. For @NTSAD#DayofHope, we’re coming together to show support for the Tay-Sachs & Sandhoff disease community who inspire our work every single day.
@CruFootball this was truly something to behold. Brought tears to my eyes remembering 9/11 and a friend of mine who was shot down in Iraq as an Apache pilot. So much more than football at UMHB games. #d3fb
Groundbreaking! Today, we broke ground on our first #genetherapy#manufacturing facility. Learn how this facility supports our three-pillar manufacturing strategy and how the crucial work we accomplish here will help fight #rarediseases @CRBgrp @ProjectFarma
Today, we are pleased to announce the acquisition of exclusive worldwide rights to a clinical-stage AAV9 #genetherapy program, now known as TSHA-120, for the treatment of giant axonal neuropathy (GAN). Join our conference call and webcast to learn more: https://t.co/RzejLX894M